PLA2G2D and hereditary angioedema: The enzymatic activity was significantly inhibited by Me-Indoxam (an enzymatic inhibitor of several sPLA2s) (38) and RO032107A (a specific hGIIA inhibitor) (39) in both C1-INH-HAE patients and healthy donors (Figure 1D).